publication . Other literature type . Article . 2006


Fabienne Nackers;
Open Access
  • Published: 01 Oct 2006
  • Publisher: American Society of Tropical Medicine and Hygiene
  • Country: United Kingdom
BCG remains the only possible prophylactic intervention against Buruli ulcer (BU). Estimating its public health impact on BU control is an important issue. We conducted a case-control study to investigate the vaccine effectiveness of routine BCG vaccine against BU in southern Benin. From August 2002 to August 2003, BCG vaccination status was obtained for 279 clinically diagnosed BU cases and 988 age- and sex-matched neighborhood controls. BCG coverage, which was estimated by the presence of a scar or a vaccination record, was 64.5% in cases and 67.2% in controls. There was no evidence of a protective effect of routine BCG vaccination against BU in southern Benin...
Related Organizations
31 references, page 1 of 3

1. World Health Organization. The Yamoussoukro Declaration on Buruli Ulcer. Accessed March 2006. Available from http://

2. Buruli ulcer disease, 2004. Wkly Epidemiol Rec 79: 194-199.

3. Amofah G, Bonsu F, Tetteh C, Okrah J, Asamoa K, Asiedu K, Addy J, 2002. Buruli ulcer in Ghana: results of a national case search. Emerg Infect Dis 8: 167-170. [OpenAIRE]

4. Debacker M, Aguiar J, Steunou C, Zinsou C, Meyers WM, Guedenon A, Scott JT, Dramaix M, Portaels F, 2004. Mycobacterium ulcerans disease (Buruli ulcer) in rural hospital, southern Benin, 1997-2001. Emerg Infect Dis 10: 1391-1398. [OpenAIRE]

5. Marston BJ, Diallo MO, Horsburgh CR Jr, Diomande I, Saki MZ, Kanga JM, Patrice G, Lipman HB, Ostroff SM, Good RC, 1995. Emergence of Buruli ulcer disease in the Daloa region of Côte d'Ivoire. Am J Trop Med Hyg 52: 219-224. [OpenAIRE]

6. van der Werf TS, van der Graaf WT, Tappero JW, Asiedu K, 1999. Mycobacterium ulcerans infection. Lancet 354: 1013- 1018.

7. Portaels F, Zinsou C, Aguiar J, Debacker M, Biurrun Bakedano E, Guedenon A, Josse R, Lagarrigue V, Silva M, Steunou C, Meyers WM, 2003. Les atteintes osseuses dans l'ulcère de Buruli: à propos de 73 cas. Bull Seances Acad R Sci Outre Mer 49: 161-190.

8. BCG vaccination against Mycobacterium ulcerans infection (Buruli ulcer). First results of a trial in Uganda, 1969. Lancet 1: 111-115.

9. Smith PG, Revill WD, Lukwago E, Rykushin YP, 1977. The protective effect of BCG against Mycobacterium ulcerans disease: a controlled trial in an endemic area of Uganda. Trans R Soc Trop Med Hyg 70: 449-457.

10. Portaels F, Aguiar J, Debacker M, Steunou C, Zinsou C, Guédénon A, Meyers WM, 2002. Prophylactic effect of Mycobacterium bovis BCG vaccination against osteomyelitis in children with Mycobacterium ulcerans disease (Buruli ulcer). Clin Diagn Lab Immunol 9: 1389-1391. [OpenAIRE]

11. Portaels F, Aguiar J, Debacker M, Guedenon A, Steunou C, Zinsou C, Meyers WM, 2004. Mycobacterium bovis BCG vaccination as prophylaxis against Mycobacterium ulcerans osteomyelitis in Buruli ulcer disease. Infect Immun 72: 62-65.

12. Amofah GK, Sagoe-Moses C, Adjei-Acquah C, Frimpong EH, 1993. Epidemiology of Buruli ulcer in Amansie West district, Ghana. Trans R Soc Trop Med Hyg 87: 644-645.

13. Raghunathan PL, Whitney EA, Asamoa K, Stienstra Y, Taylor TH Jr, Amofah GK, Ofori-Adjei D, Dobos K, Guarner J, Martin S, Pathak S, Klutse E, Etuaful S, van der Graaf WT, van der Werf TS, King CH, Tappero JW, Ashford DA, 2005. Risk factors for Buruli ulcer disease (Mycobacterium ulcerans Infection): results from a case-control study in Ghana. Clin Infect Dis 40: 1445-1453. [OpenAIRE]

14. Debacker M, Portaels F, Aguiar J, Steunou C, Zinsou C, Meyers WM, Dramaix M, 2006. Risk factors for Buruli ulcer, Benin. Emerg Infect Dis. Available at EID/vol12no09/05-0598htm. [OpenAIRE]

15. Johnson RC, Makoutode M, Sopoh GE, Elsen P, Gbovi J, Pouteau LH, Meyers WM, Boko M, Portaels F, 2005. Buruli ulcer distribution in Benin. Emerg Infect Dis 11: 500-501. [OpenAIRE]

31 references, page 1 of 3
Powered by OpenAIRE Research Graph
Any information missing or wrong?Report an Issue